SEC Form D · filed June 5, 2018
Kronos Bio, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (19)
Christopher M. Wilfong · New York, NYExecJoshua A. Kazam · New York, NYDirectorDavid M. Tanen · New York, NYExec · Director · PromoterOtello C. Stampacchia, Ph.D · New York, NYDirectorBrandon Buchanan · New York, NYDirectorRichard L. Judd · Provo, UTExecMarshall C. Greenbaum · Stamford, CTExec · Director · PromoterRebecka C. Belldegrun, M.D · New York, NYDirectorJohn C. Martin, Ph.D · New York, NYDirectorNorbert Bischofberger, Ph.D · New York, NYExec · DirectorArie S. Belldegrun, M.D · South San Francisco, CADirectorJed Millburn · Salt Lake City, UTDirectorSergio Villasenor · San Francisco, CAExecChristian R. Daher · New York, NYExec · Director · PromoterRebecka C. Belldegrun, M.D · New York, NYDirectorOtello C. Stampacchia, Ph.D · New York, NYDirectorJohn C. Martin, Ph.D · New York, NYDirectorNorbert Bischofberger, Ph.D · New York, NYExec · DirectorArie S. Belldegrun, M.D · Flemington, NJDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗